Clinical Trial Update: Study of GSK1278863 to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GSK1278863 to reduce ischemic events in patients undergoing thoracic aortic aneurysm repair has completed, with results posted in Decem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thoracic Aortic Aneurysm

Drugs mentioned

• GSK1278863

Snippet

Sponsor: GlaxoSmithKline | Conditions: Surgical Procedures | Phase 2 | Status: COMPLETED | Results posted: 2017-12-07